Skip to main content
logo
Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0140
+0.0020 (16.67%)
Oct 9, 2026, 4:10 PM AEST

Cynata Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-9.25-9.39-9.74-14.28-5.45
Depreciation & Amortization
----0.28
Other Amortization
0.260.280.280.28-
Asset Writedown & Restructuring Costs
1.35----
Stock-Based Compensation
0.130.260.230.331.03
Other Operating Activities
0000.07-0.17
Change in Accounts Receivable
0.080.030.36-0.360.02
Change in Accounts Payable
0.240.04-1.12-0.260.95
Change in Other Net Operating Assets
0.460.050.03-0.070.03
Operating Cash Flow
-6.74-8.72-9.96-14.28-3.3
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Sale (Purchase) of Intangibles
--0.05---
Investing Cash Flow
--0.05---

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Issuance of Common Stock
2.78.14-7.04-
Other Financing Activities
-0.12-0.52--0.320.21
Financing Cash Flow
2.587.61-6.720.21

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-0-0-0-0.070.17
Net Cash Flow
-4.15-1.16-9.96-7.63-2.92

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Levered Free Cash Flow
-3.82-5.44-6.61-9.38-1.27
Unlevered Free Cash Flow
-3.82-5.44-6.61-9.38-1.27

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
-1.71-1.89-2.32-1.65-0.83
Change in Working Capital
0.770.13-0.73-0.681.01